Molecular bycatch in early-stage NSCLC: Keep, discard, or redefine?
1/5 보강
OpenAlex 토픽 ·
Lung Cancer Treatments and Mutations
Lung Cancer Research Studies
Head and Neck Cancer Studies
APA
N. Frost, L. Mollica, Roberto Ferrara (2026). Molecular bycatch in early-stage NSCLC: Keep, discard, or redefine?. European journal of cancer (Oxford, England : 1990), 240, 116726. https://doi.org/10.1016/j.ejca.2026.116726
MLA
N. Frost, et al.. "Molecular bycatch in early-stage NSCLC: Keep, discard, or redefine?." European journal of cancer (Oxford, England : 1990), vol. 240, 2026, pp. 116726.
PMID
41999697 ↗
같은 제1저자의 인용 많은 논문 (2)
- PET/CT-guided management of immune checkpoint blockade and multi-modal profiling following treatment in long-term responders with metastatic lung cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM).
- Reply to Letter Re: PET/CT-Guided Management of Immune Checkpoint Blockade and Post-Treatment Multi-Modal Profiling in Long-Term Responders with Metastatic Lung Cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM).